Blog
RSS FeedPosted by Michael Wonder on 10 Mar 2020
Decision to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis
10 March 2020 - PHARMAC is pleased to announce the approval of a decision to fund a new topical psoriasis ...
Posted by Michael Wonder on 09 Mar 2020
Reports of epilepsy drug harm increase 30-fold since PHARMAC switches brands
7 March 2020 - Reports of people harmed while taking epilepsy drugs is 30 times what it was before PHARMAC ...
Posted by Michael Wonder on 06 Mar 2020
PHARMAC places temporary dispensing limits on paracetamol
6 March 2020 - PHARMAC is placing temporary dispensing limits on Government-funded paracetamol from Monday 9 March 2020. ...
Posted by Michael Wonder on 05 Mar 2020
Life-extending breast cancer drug Ibrance to be fully funded from April
5 March 2020 - Wiki Mulholland, who has advanced breast cancer, and her husband Malcolm have long been campaigning to get ...
Posted by Michael Wonder on 04 Mar 2020
PHARMAC confirms new breast cancer medicine to be funded
4 March 2020 - New Zealanders with advanced breast cancer will be able to access palbociclib (marketed as Ibrance) from ...
Posted by Michael Wonder on 04 Mar 2020
Restrictions to New Zealand's supply of drugs likely as coronavirus fears grow
4 March 2020 - New Zealand's drug buying agency PHARMAC says disruptions to the supply of some medicines are inevitable ...
Posted by Michael Wonder on 02 Mar 2020
PHARMAC's handling of funding request for sanitary products labelled 'devious' and 'underhanded'
3 March 2020 - Last August Dr Sarah Donovan from the University of Otago applied to the drug buying agency, ...
Posted by Michael Wonder on 02 Mar 2020
Coronavirus (COVID-19): PHARMAC's response
2 March 2020 - With the outbreak of novel coronavirus, it’s inevitable that there will be disruptions to supply chains ...
Posted by Michael Wonder on 02 Mar 2020
Changes to dispensing frequency rules and ‘stat’ medicines list
2 March 2020 - PHARMAC is seeking feedback on a proposal about the frequency of dispensing of pharmaceuticals in the ...
Posted by Michael Wonder on 29 Feb 2020
New Zealand Pharmaceutical Schedule - 1 March 2020
1 March 2020 - The March 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Feb 2020
Fluoxetine depression pill shortage: PHARMAC 'playing with people's lives', pharmacist warns
28 February 2020 - A shortage of New Zealand's most common anti-depressant and a switch in the drug's supplier has ...
Posted by Michael Wonder on 26 Feb 2020
Vertex announces availability of cystic fibrosis medicine Kalydeco (ivacaftor) in New Zealand
25 February 2020 - Vertex Pharmaceuticals today announced that Kalydeco (ivacaftor) will be available to eligible patients with cystic fibrosis ...
Posted by Michael Wonder on 26 Feb 2020
Decision to fund ivacaftor (Kalydeco) for people with cystic fibrosis with the G551D mutation
26 February 2020 - PHARMAC is pleased to announce a decision to fund ivacaftor (Kalydeco) for the treatment of people ...
Posted by Michael Wonder on 25 Feb 2020
FundaPen initiative extended to all Kiwis in need of life-saving Epipen auto-injectors
24 February 2020 - The FundaPen campaign, which last year saw hundreds of free EpiPens® given to children in need, ...
Posted by Michael Wonder on 25 Feb 2020
Everyone wants to help, but still the red tape prevents Dylan Barker getting medicine
25 February 2020 - Dylan Barker lives with a rare genetic condition turning muscles, tendons and ligaments to bone, locking ...